Orteronel; 6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-c]咪唑-7-基]-N-甲基-2-萘甲酰胺 6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide CAS号566939-85-3分子式、结构式、MSDS、物化性质、用途-化学科研者一站式服务平台

化合物简介

Orteronel (TAK-700) is a non-steroidal antiandrogen that was being developed for the treatment of cancer by Takeda Pharmaceutical Company in conjunction with Millennium Pharmaceuticals. It completed two phase III clinical trials for metastatic, hormone-refractory prostate cancer but failed to extend overall survival rates, and development was voluntarily terminated as a result.

基本信息

CAS：566939-85-3
中文别名：
英文别名：TAK-700-Orteronel;TAK 700;Orteronel;
分子式：C18H17N3O2
分子量：307.346
精确质量：307.132
Psa：67.15
Logp：2.4264